Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study.

@article{Rigopoulos2006TacrolimusO0,
  title={Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study.},
  author={Dimitris Rigopoulos and Stamatis Gregoriou and Christina Charissi and George J Kontochristopoulos and Dimitrios C Kalogeromitros and Sophia Georgala},
  journal={The British journal of dermatology},
  year={2006},
  volume={155 1},
  pages={152-5}
}
BACKGROUND Pityriasis alba (PA) is a frequent reason for dermatological consultation because of its chronic course, tendency to relapse and aesthetic impact. OBJECTIVES In view of its strong association with atopic dermatitis, the objective of this open-label study was to assess the efficacy and safety of tacrolimus ointment in the treatment of PA compared with the efficacy of moisturizers. PATIENTS/METHODS The study population consisted of 60 individuals of phototype III or IV according to… CONTINUE READING